221.50
전일 마감가:
$220.16
열려 있는:
$218.17
하루 거래량:
978.96K
Relative Volume:
1.10
시가총액:
$15.92B
수익:
$2.88B
순이익/손실:
$499.60M
주가수익비율:
32.86
EPS:
6.74
순현금흐름:
$321.60M
1주 성능:
-1.52%
1개월 성능:
-4.67%
6개월 성능:
-26.12%
1년 성능:
-42.90%
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
WST을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
WST
West Pharmaceutical Services Inc
|
221.50 | 15.92B | 2.88B | 499.60M | 321.60M | 6.74 |
![]()
ISRG
Intuitive Surgical Inc
|
507.05 | 177.83B | 8.35B | 2.32B | 1.30B | 6.41 |
![]()
BDX
Becton Dickinson Co
|
226.42 | 66.11B | 20.64B | 1.73B | 2.94B | 6.02 |
![]()
ALC
Alcon Inc
|
92.59 | 45.80B | 9.91B | 1.02B | 665.00M | 2.05 |
![]()
RMD
Resmed Inc
|
223.00 | 32.66B | 4.93B | 1.25B | 1.38B | 8.47 |
![]()
BAX
Baxter International Inc
|
33.65 | 17.26B | 17.28B | 108.00M | 391.00M | 0.20 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-03-18 | 개시 | Evercore ISI | Outperform |
2025-02-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
2025-01-08 | 개시 | Citigroup | Buy |
2024-12-13 | 개시 | Wolfe Research | Peer Perform |
2024-12-12 | 업그레이드 | UBS | Neutral → Buy |
2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
2022-12-14 | 개시 | Deutsche Bank | Hold |
2022-11-30 | 개시 | UBS | Neutral |
2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
2020-10-14 | 개시 | Stephens | Equal-Weight |
2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
2019-04-23 | 개시 | William Blair | Outperform |
2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
2018-01-24 | 개시 | Goldman | Neutral |
2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
2017-10-03 | 개시 | Stephens | Equal-Weight |
2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
2016-03-22 | 개시 | Wells Fargo | Outperform |
2010-05-14 | 재확인 | UBS | Neutral |
2010-02-23 | 개시 | Jefferies & Co | Buy |
2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud AllegationsWST - ACCESS Newswire
National Wealth Management Group LLC Makes New $706,000 Investment in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Pharmaceutical Testing Services Market Set to Witness - openPR.com
WST ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your West Pharmaceutical Services, Inc. investment - ACCESS Newswire
How Is The Market Feeling About West Pharmaceutical Servs? - Benzinga
West Pharmaceutical Services, Inc. (WST) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - ACCESS Newswire
Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks - Yahoo Finance
West Pharmaceutical Services (NYSE:WST) Proposes Bylaw Changes; Share Price Remains Flat - Yahoo Finance
Is West Pharmaceutical Services Stock Underperforming the S&P 500? - Nasdaq
Is West Pharmaceutical Services Stock Underperforming The S&P 500? - Barchart
West Pharmaceutical at KeyBanc Forum: Strategic Growth Amid Challenges - Investing.com
West Pharmaceutical at KeyBanc Forum: Strategic Growth Amid Challenges By Investing.com - Investing.com UK
UBS maintains Buy on West Pharma, reiterates $285 target By Investing.com - Investing.com Canada
UBS maintains Buy on West Pharma, reiterates $285 target - Investing.com
Did West Pharmaceutical Services, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- WST - ACCESS Newswire
This West Pharmaceutical Services Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga India
Evercore ISI sets $275 target on West Pharmaceutical stock - Investing.com
Evercore ISI sets $275 target on West Pharmaceutical stock By Investing.com - Investing.com UK
Evercore ISI Initiates West Pharmaceutical Services at Outperform With $275 Price Target - MarketScreener
Managing Risks In Injectable Drug Delivery Solutions For Todays Drug Products And Tomorrows Novel Applications - Bioprocess Online
West Pharmaceutical at Barclays Healthcare: Strategic Growth Amid Challenges - Investing.com India
West Pharmaceutical at Barclays Healthcare: Strategic Growth Amid Challenges By Investing.com - Investing.com South Africa
West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your RightsWST - ACCESS Newswire
On-Body Drug Delivery Devices Market to Hit $ 82.74 Bn by 2033Key - openPR
Jones Financial Companies Lllp Grows Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
West Pharmaceutical Announces Leadership Transition - TipRanks
Meeting Annex 1 Regulations: A Proactive Approach To Regulatory Compliance - Med Device Online
Lost Money on West Pharmaceutical Services, Inc. (WST)? You May Have Been Affected by FraudContact Levi & Korsinsky - ACCESS Newswire
West Pharmaceutical: Remains A Strong Long-Term Prospect (NYSE:WST) - Seeking Alpha
West Pharmaceutical Services to Present at Major 2025 Healthcare Conferences - MSN
Zacks Research Has Bearish Estimate for WST Q1 Earnings - Defense World
Why West Pharmaceutical Services, Inc. (WST) Is Plunging So Far In 2025 - Insider Monkey
A Look At The Intrinsic Value Of West Pharmaceutical Services, Inc. (NYSE:WST) - Yahoo Finance
FY2027 Earnings Forecast for WST Issued By Zacks Research - Defense World
West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet - Simply Wall St
West to Participate in Upcoming Investor Conferences -March 05, 2025 at 06:01 am EST - Marketscreener.com
West to Participate in Upcoming Investor Conferences - Quantisnow
West Pharmaceutical Sets Key Investor Conference ScheduleHow to Access Their March Presentations - Stock Titan
Lost Money on West Pharmaceutical Services, Inc.(WST)? You May Have Been Affected by FraudContact Levi & Korsinsky - ACCESS Newswire
Private Advisor Group LLC Trims Position in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
Achieving EU GMP Annex 1 Compliance Through An End-To-End Approach To Contamination Control - Med Device Online
West Pharmaceutical Services, Inc. (NYSE:WST) Receives $344.00 Consensus Target Price from Brokerages - Defense World
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MSN
West Pharmaceutical's Long-Term Growth Intact, but Margin Expansion Less Uncertain - Morningstar
Do Wall Street Analysts Like West Pharmaceutical Services Stock? - MSN
Levi & Korsinsky Investigates Possible Securities Fraud Violations by West Pharmaceutical Services, Inc. (WST) - ACCESS Newswire
Healthcare Visual Inspection Services Market Report, 2030 - Grand View Research
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):